Patent · US Active

Compositions and methods for treatment of insulin resistance

US10729670B2 · kind B2 · utility

1Cited by

10References

9Claims

0Family size

Assignee

Temple University-Of The Commonwealth System of Higher Education · US

Inventors

Salim Merali · Queens, US
Carlos A. Barrero · Philadelphia, US
Wayne E. Childers · New Hope, US
George C. Morton · Collegeville, US

Key dates

Filing date	Sep 7, 2017
Grant date	Aug 4, 2020
Priority date	—
Expiry date	Sep 7, 2037

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P3/08
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compounds of Formula (I), and pharmaceutically effective salts thereof; wherein R1-R14, m, n, o, p, q and r are as defined herein, are provided for treatment of for increasing insulin sensitivity, reducing insulin resistance, preventing insulin resistance and treating insulin resistance disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.